Skip to main
BIOX
BIOX logo

BIOX Stock Forecast & Price Target

BIOX Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Bioceres Crop Solutions demonstrates strong potential due to its diversified product offerings and successful penetration in international markets, particularly with its crop protection portfolio. The company's robust positioning in bio-protection and adjuvant sales outside Argentina indicates a balanced revenue stream, which helps mitigate weaker performance in its domestic market. Additionally, the anticipated growth opportunities for HB4 wheat revenue in key regions such as the US, Brazil, and Australia contribute to a favorable long-term outlook.

Bears say

Bioceres Crop Solutions has reported a significant decline in revenue due to weaker demand for its Crop Protection and Crop Nutrition solutions in Argentina, which has negatively impacted financial performance. The company's transition to a licensing-based model has led to a dramatic 75% year-over-year decrease in Seed & Integrated products revenue, falling to approximately $8 million. Additionally, the Crop Nutrition segment experienced a sharp decline of around 34% year-over-year, reflecting challenging market conditions and reduced acreage for corn production, resulting in pricing pressures for fertilizers in Argentina.

BIOX has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Bioceres Crop Solutions Corp (BIOX) Forecast

Analysts have given BIOX a Buy based on their latest research and market trends.

According to 3 analysts, BIOX has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Bioceres Crop Solutions Corp (BIOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.